Clinical trial
Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
NCT01971190 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- May 31, 2015
- Enrollment
- 43 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.